Catherine Leroux-Marchand

Inserm UMR S 1144 Optimisation Thérapeutique En Neuropsychopharmacologie, 4 Avenue De L'Observatoire
Paris, 75006, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

From positron emission tomography to cell analysis of the 18-kDa Translocator Protein in mild traumatic brain injury.

From positron emission tomography to cell analysis of the 18-kDa Translocator Protein in mild traumatic brain injury.

Journal: Scientific reports

Published: December 02, 2020

Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?

Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?

Journal: Fundamental & clinical pharmacology

Published: July 28, 2020

Insulin-like Growth Factors may be Markers of both Traumatic Brain Injury and Fear-Related Stress.

Insulin-like Growth Factors may be Markers of both Traumatic Brain Injury and Fear-Related Stress.

Journal: Neuroscience

Published: June 18, 2020

Histological and Behavioral Evaluation after Traumatic Brain Injury in Mice: A Ten Months Follow-Up Study.

Histological and Behavioral Evaluation after Traumatic Brain Injury in Mice: A Ten Months Follow-Up Study.

Journal: Journal of neurotrauma

Published: December 14, 2019

Behavioral tests that reveal long-term deficits after permanent focal cerebral ischemia in mouse.

Behavioral tests that reveal long-term deficits after permanent focal cerebral ischemia in mouse.

Journal: Behavioural brain research

Published: July 16, 2018

Spontaneous resurgence of conditioned fear weeks after successful extinction in brain injured mice.

Spontaneous resurgence of conditioned fear weeks after successful extinction in brain injured mice.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: April 23, 2018

Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice.

Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice.

Journal: Molecular neurobiology

Published: February 04, 2018

Sex differences in the effects of PARP inhibition on microglial phenotypes following neonatal stroke.

Sex differences in the effects of PARP inhibition on microglial phenotypes following neonatal stroke.

Journal: Brain, behavior, and immunity

Published: November 27, 2017

Neuroinflammation, myelin and behavior: Temporal patterns following mild traumatic brain injury in mice.

Neuroinflammation, myelin and behavior: Temporal patterns following mild traumatic brain injury in mice.

Journal: PloS one

Published: July 27, 2016

Recombinant tissue plasminogen activator enhances microparticle release from mouse brain-derived endothelial cells through plasmin.

Recombinant tissue plasminogen activator enhances microparticle release from mouse brain-derived endothelial cells through plasmin.

Journal: Journal of the neurological sciences

Published: July 29, 2015

Another "string to the bow" of PJ34, a potent poly(ADP-Ribose)polymerase inhibitor: an antiplatelet effect through P2Y12 antagonism?

Another "string to the bow" of PJ34, a potent poly(ADP-Ribose)polymerase inhibitor: an antiplatelet effect through P2Y12 antagonism?

Journal: PloS one

Published: May 20, 2014

CB1 and CB2 cannabinoid receptor antagonists prevent minocycline-induced neuroprotection following traumatic brain injury in mice.

CB1 and CB2 cannabinoid receptor antagonists prevent minocycline-induced neuroprotection following traumatic brain injury in mice.

Journal: Cerebral cortex (New York, N.Y. : 1991)

Published: August 21, 2013

Showing 1-12 of 23

Last Updated: 09/26/2026